Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,711 recalls, newest first

Class II · Moderate risk

lidocaine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0063-2017
Class II · Moderate risk

lidocaine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0062-2017
Class II · Moderate risk

lidocaine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0061-2017
Class II · Moderate risk

lidocaine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0060-2017
Class II · Moderate risk

lidocaine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0059-2017
Class II · Moderate risk

labetalol HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0058-2017
Class II · Moderate risk

ketamine HCl Injection

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0057-2017
Class II · Moderate risk

ketamine HCl Injection

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0056-2017
Class II · Moderate risk

ketamine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0055-2017
Class II · Moderate risk

ketamine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0054-2017
Class II · Moderate risk

ketamine HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0053-2017
Class II · Moderate risk

HYDROmorphone HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0052-2017
Class II · Moderate risk

HYDROmorphone HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0051-2017
Class II · Moderate risk

HYDROmorphone HCl

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0050-2017
Class II · Moderate risk

HEPARIN Sodium Inj. USP

Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.

Terminated Wrong potency / content Pharmedium Services, LLC D-0049-2017
Class II · Moderate risk

HEPARIN Sodium Inj.

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0048-2017
Class II · Moderate risk

HEPARIN Sodium Inj. USP

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0047-2017
Class II · Moderate risk

glycopyrrolate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0046-2017
Class II · Moderate risk

glycopyrrolate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0045-2017
Class II · Moderate risk

glycopyrrolate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0044-2017
Class II · Moderate risk

fentaNYL Citrate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0043-2017
Class II · Moderate risk

fentaNYL Citrate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0042-2017
Class II · Moderate risk

fentaNYL Citrate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0041-2017
Class II · Moderate risk

fentaNYL Citrate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0040-2017
Class II · Moderate risk

fentaNYL Citrate

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0039-2017

Recalls by year